Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 8/20 | 0.74 |
| ▸ | EPHX2 | P34913 | 4/20 | 0.50 |
| ▸ | MMP2 | P08253 | 2/20 | 0.50 |
| ▸ | ACHE | P22303 | 2/20 | 0.50 |
| ▸ | MMP1 | P03956 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1753987 | 0.93 | EPHX1 (0.82) | EPHX1EPHX2 | |
| SCHEMBL320112 | 0.92 | EPHX1 (0.85) | EPHX1MMP2ACHEMMP1 | |
| SCHEMBL6290324 | 0.91 | EPHX1 (0.69) | EPHX1EPHX2 | |
| SCHEMBL6290512 | 0.91 | EPHX1 (0.63) | EPHX1EPHX2MMP2ACHEMMP1 | |
| SCHEMBL25270954 | 0.91 | EPHX1 (0.86) | EPHX1EPHX2 | |
| SCHEMBL8392636 | 0.91 | EPHX1 (0.86) | EPHX1EPHX2 | |
| SCHEMBL8391736 | 0.91 | EPHX1 (0.86) | EPHX1EPHX2 | |
| SCHEMBL25274521 | 0.91 | EPHX1 (0.86) | EPHX1EPHX2 | |
| SCHEMBL11236288 | 0.91 | EPHX1 (0.86) | EPHX1EPHX2 | |
| SCHEMBL8392235 | 0.91 | EPHX1 (0.86) | EPHX1EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-4270257-A | — | — | None | — | — | JP | disclosed |
| EP-4446310-A1 | METHOD FOR PRODUCING BLOCKED ISOCYANATE COMPOUND AND METHOD FOR PRODUCING ISOCYANATE COMPOUND | Asahi Kasei Kabushiki Kaisha (JP) | 2024-10-16 | — | — | EP | disclosed |
| CN-118382612-A | Method for producing blocked isocyanate compound and method for producing isocyanate compound | 旭化成株式会社 | 2024-07-23 | — | — | CN | disclosed |
| CN-110546566-B | Positive photosensitive siloxane composition and cured film formed using same | 默克专利有限公司 | 2024-02-09 | — | — | CN | disclosed |
| US-11860537-B2 | Positive type photosensitive siloxane composition and cured film formed by using the same | MERCK PATENT GMBH (DE) | 2024-01-02 | — | — | US | disclosed |
| US-20230322785-A1 | ADENOSINE A2A AND A2B RECEPTOR DUAL ANTAGONISTS FOR IMMUNO-ONCOLOGY | MERCK SHARP & DOHME LLC (US) | 2023-10-12 | — | — | US | disclosed |
| WO-2023106377-A1 | METHOD FOR PRODUCING BLOCKED ISOCYANATE COMPOUND AND METHOD FOR PRODUCING ISOCYANATE COMPOUND | 旭化成株式会社 | 2023-06-15 | — | — | WO | disclosed |
| US-20230151034-A1 | PEPTIDOMIMETIC N5-METHYL-N2-(NONANOYL-L-LEUCYL)-L-GLUTAMINATE DERIVATIVES, TRIAZASPIRO[4.14]NONADECANE DERIVATIVES AND SIMILAR COMPOUNDS AS INHIBITORS OF NOROVIRUS AND CORONAVIRUS REPLICATION | COCRYSTAL PHARMA, INC. | 2023-05-18 | — | — | US | disclosed |
| US-20210116811-A1 | POSITIVE TYPE PHOTOSENSITIVE SILOXANE COMPOSITION AND CURED FILM FORMED BY USING THE SAME | MERCK PATENT GMBH (DE) | 2021-04-22 | — | — | US | disclosed |
| WO-2021061823-A1 | CHEMICAL COMPOUNDS | Boragen, Inc. (US) | 2021-04-01 | — | — | WO | disclosed |
| US-5459147-A | Angeotensin-antagonistic effects; hypotensive, antiischemic, and antidiabetic agents, treating glaucoma | DR. KARL THOMAE GMBH (DE) | 1995-10-17 | — | — | US | disclosed |
| US-5194660-A | Processes for producing carbamates and isocyanates | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) | 1993-03-16 | — | — | US | disclosed |
| US-5169954-A | Process for the N-alkylation of ureas | CHEMIE LINZ GESELLSCHAFT M.B.H. (AT) | 1992-12-08 | — | — | US | disclosed |
| JP-H04270257-A | N-ALKYLATION OF UREA COMPOUND | CHEM LINZ AG | 1992-09-25 | — | — | JP | disclosed |
| US-5124451-A | PROCESS FOR THE N-ALKYLATION OR UREAS | CHEMIE LINZ GESELLSCHAFT M.B.H. (AT) | 1992-06-23 | — | — | US | disclosed |
| EP-0083096-B1 | PRODUCTION OF URETHANE COMPOUNDS | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1987-02-25 | — | — | EP | disclosed |
| US-4621149-A | PLATINUM GROUP METAL HALOGEN OR HALOGEN COMPOUND | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1986-11-04 | — | — | US | disclosed |
| EP-0083096-A2 | Production of urethane compounds | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1983-07-06 | — | — | EP | disclosed |
| US-4388245-A | OF LOW VISCOSITY | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1983-06-14 | — | — | US | disclosed |
| US-3976622-A | POLYURETHANES | BAYER AKTIENGESELLSCHAFT (DT) | 1976-08-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230151034-A1 | PEPTIDOMIMETIC N5-METHYL-N2-(NONANOYL-L-LEUCYL)-L-GLUTAMINATE DERIVATIVES, TRIAZASPIRO[4.14]NONADECANE DERIVATIVES AND SIMILAR COMPOUNDS AS INHIBITORS OF NOROVIRUS AND CORONAVIRUS REPLICATION | ASNS, GLUL, GNMT | EPHX1 4343/4885EPHX2 4433/4885MMP2 231/4885 |
| US-20230322785-A1 | ADENOSINE A2A AND A2B RECEPTOR DUAL ANTAGONISTS FOR IMMUNO-ONCOLOGY | ADORA2A, ADORA2B, ADORA1 | EPHX1 1759/4885EPHX2 564/4885MMP2 3870/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.